Swedish Orphan Biovitrum ROE - Return on Equity 2019-2024 | BIOVF

Swedish Orphan Biovitrum return on equity for the quarter ending June 30, 2024 was 6.11.

  • Swedish Orphan Biovitrum average return on equity for 2023 was 10.22, a 5.63% decline from 2022.
  • Swedish Orphan Biovitrum average return on equity for 2022 was 10.83, a 20.13% decline from 2021.
  • Swedish Orphan Biovitrum average return on equity for 2021 was 13.56, a 27.37% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Swedish Orphan Biovitrum ROE - Return on Equity 2019-2024 | BIOVF

  • Swedish Orphan Biovitrum average return on equity for 2023 was 10.22, a 5.63% decline from 2022.
  • Swedish Orphan Biovitrum average return on equity for 2022 was 10.83, a 20.13% decline from 2021.
  • Swedish Orphan Biovitrum average return on equity for 2021 was 13.56, a 27.37% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.